Stable expression of a retrovirally transferred adhesion molecule in a human melanoma-specific cytotoxic T lymphocyte clone

Cancer Immunology Immunotherapy

Volumn 46, Issue 1, 1998, Pages 61-66

  Cochlovius, Björn ^a   Zawadzki, Volker ^a   Perschl, Astrid ^a   Zöller, Margot ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Cytotoxic T lymphocytes; Gene transfer; Retroviral transduction

Indexed keywords

CD14 ANTIGEN; MELANOMA ANTIGEN;

ADOPTIVE TRANSFER; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MELANOMA; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RETROVIRUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD44; GENETIC VECTORS; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0031940421     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050461     Document Type: Article

References (37)

1. Abonour R, Cigel FK, Schell K, Barnstable CS, Sabatini LM, Malkovska V (1995) Survival and tissue distribution of human T-cell clones in SCID mice. J Immunother 18:10
2. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatidis envelope glycoprotein G. J Virol 70:2581
3. Arca MJ, Mule JJ, Chang AE (1996) Genetic approaches to adoptive cellular therapy of malignancy. Semin Oncol 23:108
4. Braakman E, Beusechem VW van, Krimpen VA van, Fischer A, Bolhuis RL, Valerio D (1992) Genetic correction of cultured T cells from a adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells. Eur J Immunol 22:63
5. Boon T, Bruggen P van der (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725
6. Brenner MK (1993) Gene transfer into human hematopoetic progenitor cells: a review of current clinical protocols. J Hemotother 2:7
7. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA (1995) High-efficiency retroviral-mediated gene transfer into human and non-human primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 92:7739
8. Cai Q, Rubin JT, Lotze MT (1995) Genetically marking human cells - results of the first clinical gene transfer studies. Cancer Gene Ther 2:125
9. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ (1976) Cell surface antigens of malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 73:3278
10. Chang AE, Shu S (1996) Current status of adoptive immunotherapy of cancer. Crit Rev Oncol Hematol 22:213
11. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745
12. Culver KW, Osborne WR, Miller AD, Fleisher TA, Berger M, Anderson WF, Blaese RM (1991) Correction of ADA deficiency in human T lymphocytes using retroviral mediated gene transfer. Transplant Proc 23:170
13. Degiovanni G, Lahaye T, Herin M, Hainaut P, Boon T (1988) Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur J Immunol 18:671
14. Finer MH, Dull TJ, Qin L, Farson D, Roberts MR (1994) Kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43
15. Finn OJ, Persons DA, Bendt KM, Pirami L, Ricciardi P (1991) Retroviral transduction of protein-kinase C-gamma into cytolytic T-lymphocyte clones leads to immortalization with retention of specific function. J Immunol 146:1099
16. Gattoni-Celli S, Cole DJ (1996) Melanoma-associated tumor antigens and their clinical relevance to immunotherapy. Semin Oncol 23:754
17. Hosken NA, Bevan MJ (1990) Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science 248:367
18. Hwu P, Yanelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mule J, et al (1993) Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for gene therapy of cancer in humans. J Immunol 150:4104
19. Hwu P, Shafer GE, Treisman J, Schindler DG, Gross G, Cowherd R, Rosenberg SA, Eshhar Z (1993) Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med 178:361
20. Jerome KR, Bu D, Finn OJ (1992) Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complemantary DNA. Cancer Res 52:5985
21. Kasid A, Morecki S, Aeversold P, Cornetta K, Culver K, Freeman S, Director E, Lotze MT, Blaese RM, Anderson WF, et al (1990) Human gene transfer: characterization of human tumor-infiltrating lyumphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 87:473
22. Kirschmeier PT, Housey GM, Johnson MD, Perkins AS, Weinstein IB (1988) Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA 7:219
23. Lynch CM, Miller CA (1991) Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J Virol 65:3887
24. Maeurer MJ, Storkus WJ, Kirkwood JM, Lotze MT (1996) New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide-vaccines. Melanoma Res 6:11
25. Markowitz D, Goff S, Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120
26. Matzinger P (1991) The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185
27. Melief CJM, Kast M (1995) T-cell immunotherapy or tumors by adoptive transfer of cytotoxic T-lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev 15
28. Miller AD, Buttimore C (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895
29. Mukherij B, Chakraborty NG (1995) Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 7:175
30. Nottenburg C, Rees G, St John T (1989) Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. Proc Natl Acad Sci USA 86:8521
31. Rösel M, Seiter S, Zöller M (1997) CD44v10 expression in the mouse and functional activity in delayed hypersensitivity. J Cell Physiol 171:305
32. Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, Möller P, Zöller M (1996) Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 428:141
33. Talento A, Nguyen M, Law S, Wu JK, Poe M, Blake JT, Patel M, Wu TJ, Manyak CL, Silberklang M, et al (1992) Transfection of mouse cytotoxic T lymphocytes with antisense granzyme A vector reduces lytic activity. J Immunol 149:4009
34. Tary-Lehmann M, Saxon A, Lehmann PV (1995) The human immune system in hu-PBL-SCID mice. Immunol Today 16:529
35. Treisman J, Hwu P, Minamoto S, Shafer GE, Cowherd R, Morgan RA, Rosenberg SA (1995) Interleukin-2-transduced lymphocytes grow in autocrine fashion and remain responsive to antigen. Blood 85:139
36. Weijtens MEM, Willemsen RA, Valerio D, Stam K, Bolhuis RLH (1996) Single chain Ig/γ gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells and recycle lytic capacity. J Immunol 157:836
37. Weisdorf DJ, Verfaille CM, Miller WJ, Blazar BR, Perry E, Shu XO, Daniels K, Hannan P, Ramsay NK, Kersey JH, McGlave PB (1997) Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective comparative trial. Am J Hematol 54:202